A Multifaceted Evaluation of National Off-label Neurology Applications.
- Published in:
- Turkish Journal of Neurology / Turk Noroloji Dergisi, 2020, v. 26, n. 3, p. 235, doi. 10.4274/tnd.2020.37791
- By:
- Publication type:
- Article
Works matching DE "OFF-label use of drug laws"
Results: 48
1
2
WHEN TRUTH CANNOT BE PRESUMED: THE REGULATION OF DRUG PROMOTION UNDER AN EXPANDING FIRST AMENDMENT.
- Published in:
- 2014
- By:
- Publication type:
- Essay
3
Current Perceptions and Trends Regarding Off-Label Use of Topical Ophthalmics.
- Published in:
- Ocular Surgery News, 2011, p. 11
- By:
- Publication type:
- Article
4
OFF-LABEL SPEECH.
- Published in:
- Emory Law Journal, 2023, v. 72, n. 3, p. 549
- By:
- Publication type:
- Article
5
Differences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin.
- Published in:
- PLoS Medicine, 2013, v. 10, n. 1, p. 1, doi. 10.1371/journal.pmed.1001378
- By:
- Publication type:
- Article
6
Rooting Out Institutional Corruption to Manage Inappropriate Off-Label Drug Use.
- Published in:
- Journal of Law, Medicine & Ethics, 2013, v. 41, n. 3, p. 654, doi. 10.1111/jlme.12075
- By:
- Publication type:
- Article
7
Recent Case Developments in Health Law.
- Published in:
- Journal of Law, Medicine & Ethics, 2010, v. 38, n. 3, p. 708, doi. 10.1111/j.1748-720X.2010.00524.x
- By:
- Publication type:
- Article
8
Unlicensed medicines.
- Published in:
- British Journal of Nursing, 2019, v. 28, n. 17, p. 1154, doi. 10.12968/bjon.2019.28.17.1154
- By:
- Publication type:
- Article
9
Customized Medicine and the Limits of Federal Regulatory Power.
- Published in:
- Vanderbilt Journal of Entertainment & Technology Law, 2017, v. 19, n. 2, p. 285
- By:
- Publication type:
- Article
10
PROSPECTS FOR REGULATION OF OFF-LABEL DRUG PROMOTION IN AN ERA OF EXPANDING COMMERCIAL SPEECH PROTECTION.
- Published in:
- North Carolina Law Review, 2014, v. 92, n. 5, p. 1539
- By:
- Publication type:
- Article
11
Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?
- Published in:
- British Journal of Cancer, 2012, v. 106, n. 1, p. 14, doi. 10.1038/bjc.2011.544
- By:
- Publication type:
- Article
12
Off-label prescribing.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
13
Off-Label: Combating the Dangerous Overprescription of Amphetamines to Children.
- Published in:
- George Washington Law Review, 2013, v. 82, n. 1, p. 174
- By:
- Publication type:
- Article
14
PSYCHOTROPIC MEDICATION AND FOSTER CARE CHILDREN: A PRESCRIPTION FOR STATE OVERSIGHT.
- Published in:
- Southern California Law Review, 2012, v. 85, n. 2, p. 395
- By:
- Publication type:
- Article
15
After Caronia: First Amendment Concerns in Off-Label Promotion.
- Published in:
- San Diego Law Review, 2014, v. 51, n. 3, p. 645
- By:
- Publication type:
- Article
16
The Informational and Institutional Theories of Off-Label Promotion.
- Published in:
- San Diego Law Review, 2012, v. 49, n. 3, p. 913
- By:
- Publication type:
- Article
17
STOPPING THE CONFUSION: WHY WIDENING THE PREEMPTION GAP THROUGH THE PARALLEL-CLAIMS EXCEPTION PROMOTES OFF-LABEL USES OF MEDICAL DEVICES.
- Published in:
- Jurimetrics: The Journal of Law, Science & Technology, 2019, v. 60, n. 1, p. 83
- By:
- Publication type:
- Article
18
The View from the Inside: More Confusion (and Coziness) Than Consent.
- Published in:
- American Journal of Bioethics, 2010, v. 10, n. 9, p. 60, doi. 10.1080/15265161.2010.505142
- By:
- Publication type:
- Article
19
Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 2, p. 144, doi. 10.1111/jcpt.12119
- By:
- Publication type:
- Article
20
Promoting the Off-label Use of Medicines: Where to Draw the Line?
- Published in:
- European Journal of Risk Regulation, 2016, v. 7, n. 2, p. 426, doi. 10.1017/S1867299X00005845
- By:
- Publication type:
- Article
21
Off-Label Drug Promotion and the Use of Disclaimers.
- Published in:
- Texas Law Review, 2013, v. 92, n. 1, p. 231
- By:
- Publication type:
- Article
22
OFF-LABEL PROMOTION, THE FIRST AMENDMENT, AND PRACTICALLY ADDRESSING ANTIBIOTIC RESISTANCE.
- Published in:
- California Western Law Review, 2015, v. 51, n. 2, p. 293
- By:
- Publication type:
- Article
23
Projects seek hidden effects of cancer drugs.
- Published in:
- Nature, 2014, v. 516, n. 7529, p. 21, doi. 10.1038/516021a
- By:
- Publication type:
- Article
24
Off-label drugs use in pediatric palliative care.
- Published in:
- 2018
- By:
- Publication type:
- Letter
25
What Is "False or Misleading" Off-Label Promotion?
- Published in:
- 2015
- By:
- Publication type:
- Opinion
26
What Is "False or Misleading" Off-Label Promotion?
- Published in:
- 2015
- By:
- Publication type:
- Opinion
27
Off-Label Prescribing of Medications for Pain: Maintaining Optimal Care at an Intersection of Law, Public Policy, and Ethics.
- Published in:
- Journal of Pain & Palliative Care Pharmacotherapy, 2012, v. 26, n. 2, p. 146, doi. 10.3109/15360288.2012.671243
- By:
- Publication type:
- Article
28
Off-Label Prescribing: In Search of a Reasonable Patient-Centered Approach.
- Published in:
- Journal of Pain & Palliative Care Pharmacotherapy, 2012, v. 26, n. 2, p. 131, doi. 10.3109/15360288.2012.679335
- By:
- Publication type:
- Article
29
CAVEAT EMPTOR, VENDITOR, ET PRAESCRIBOR: LEGAL LIABILITY ASSOCIATED WITH METHYPLENIDATE HYDROCHLORIDE (MPH) USE BY POSTSECONDARY STUDENTS.
- Published in:
- Health Law Journal, 2010, v. 18, p. 51
- By:
- Publication type:
- Article
30
Promotion of off-label use not always a crime.
- Published in:
- American Journal of Health-System Pharmacy, 2013, v. 70, n. 6, p. 478, doi. 10.2146/news130022
- By:
- Publication type:
- Article
31
Off-Label-Use von Arzneimitteln bei Kindern.
- Published in:
- Journal für Medizin- und Gesundheitsrecht (JMG), 2023, v. 8, n. 1, p. 32, doi. 10.33196/jmg202301003201
- By:
- Publication type:
- Article
32
Historic settlement ends deceptive off-label marketing of antipsychotics.
- Published in:
- Brown University Child & Adolescent Behavior Letter, 2012, v. 28, n. 10, p. 3
- Publication type:
- Article
33
IN DEFENSE OF THE FDA'S PROHIBITION AGAINST OFF-LABEL PHARMACEUTICAL MARKETING: THE FIRST AMENDMENT DOES NOT STAND IN THE WAY.
- Published in:
- Michigan State Law Review, 2016, v. 2016, n. 5, p. 1409
- By:
- Publication type:
- Article
34
Off-Label Marketing's Audiences: The 21<sup>st</sup> Century Cures Act and the Relaxation of Standards for Evidence-Based Therapeutic and Cost-Comparative Claims.
- Published in:
- 2018
- By:
- Publication type:
- journal article
35
Off-Label Promotion Is Protected Speech: Second Circuit Sweeps Away Pharmaceutical Representative's Misbranding Conviction Under the First Amendment.
- Published in:
- American Journal of Law & Medicine, 2013, v. 39, n. 1, p. 189, doi. 10.1017/s0098858800000150
- By:
- Publication type:
- Article
36
Off-Label Drug Use and Promotion: Balancing Public Health Goals and Commercial Speech.
- Published in:
- American Journal of Law & Medicine, 2011, v. 37, n. 2/3, p. 225, doi. 10.1177/009885881103700202
- By:
- Publication type:
- Article
37
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective.
- Published in:
- Italian Journal of Pediatrics, 2016, v. 42, p. 1, doi. 10.1186/s13052-016-0271-6
- By:
- Publication type:
- Article
38
The next forum for unraveling FDA off-label marketing rules: State and federal legislatures.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
39
The impact of legislation on drug substances used off-label in paediatric wards-a nationwide study.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 4, p. 445, doi. 10.1007/s00228-013-1626-1
- By:
- Publication type:
- Article
40
Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 505, doi. 10.1007/s00228-011-1173-6
- By:
- Publication type:
- Article
41
Ethical, legal, and regulatory issues regarding the study and use of medications in pregnant women.
- Published in:
- Journal of Commercial Biotechnology, 2014, v. 20, n. 3, p. 23, doi. 10.5912/jcb665
- By:
- Publication type:
- Article
42
US Food and Drug Administration-Approved Laboratory Tests After Caronia.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2013, v. 137, n. 11, p. 1543, doi. 10.5858/arpa.2013-0020-ED
- By:
- Publication type:
- Article
43
The Tip of the Iceberg: A First Amendment Right To Promote Drugs Off- Label.
- Published in:
- Ohio State Law Journal, 2017, v. 78, n. 4, p. 1020
- By:
- Publication type:
- Article
44
Prohibition against off-label drug promotion challenged.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2012, v. 184, n. 5, p. 518, doi. 10.1503/cmaj.109-4128
- By:
- Publication type:
- Article
45
Meeting the special medicinal needs of patients.
- Published in:
- British Journal of Community Nursing, 2016, v. 21, n. 9, p. 476, doi. 10.12968/bjcn.2016.21.9.476
- By:
- Publication type:
- Article
46
EVIDENCE AND EXTRAPOLATION: MECHANISMS FOR REGULATING OFF-LABEL USES OF DRUGS AND DEVICES.
- Published in:
- Duke Law Journal, 2014, v. 64, n. 3, p. 377
- By:
- Publication type:
- Article
47
Physicians must obtain consent for off-label use.
- Published in:
- Same-Day Surgery, 2013, v. 37, n. 4, p. 44
- Publication type:
- Article
48
Off-label use might be the standard of care.
- Published in:
- Same-Day Surgery, 2013, v. 37, n. 4, p. 43
- Publication type:
- Article